| Economic and humanistic burden associated with noncommunicable diseases among adults with depression and anxiety in the United States E Armbrecht, A Shah, P Schepman, R Shah, E Pappadopulos, ... Journal of Medical Economics 23 (9), 1032-1042, 2020 | 46 | 2020 |
| Relationship between depression and physical activity, disability, burden, and health-related quality of life among patients with arthritis N Joshi, R Khanna, RM Shah Population health management 18 (2), 104-114, 2015 | 35 | 2015 |
| Health and economic burden of obesity in elderly individuals with asthma in the United States R Shah, Y Yang Population health management 18 (3), 186-191, 2015 | 31 | 2015 |
| Economic and humanistic burden of cervical cancer in the United States: results from a nationally representative survey R Shah, C Nwankwo, Y Kwon, SL Corman Journal of women's health 29 (6), 799-805, 2020 | 30 | 2020 |
| Phase-specific and lifetime costs of multiple myeloma among older adults in the US K Bhattacharya, JP Bentley, S Ramachandran, Y Chang, BF Banahan, ... JAMA Network Open 4 (7), e2116357-e2116357, 2021 | 29 | 2021 |
| Systematic review and benchmarking of quality-adjusted time without symptoms or toxicity (Q-TWiST) in oncology CT Solem, Y Kwon, RM Shah, A Aly, MF Botteman Expert Review of Pharmacoeconomics & Outcomes Research 18 (3), 245-253, 2018 | 27 | 2018 |
| Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy A Shah, R Shah, N Kebede, A Mohamed, M Botteman, R Waldeck, ... Journal of Medical Economics 23 (4), 330-346, 2020 | 26 | 2020 |
| Overall survival, costs and healthcare resource use by number of regimens received in elderly patients with newly diagnosed metastatic triple-negative breast cancer A Aly, R Shah, K Hill, MF Botteman Future Oncology 15 (9), 1007-1020, 2019 | 24 | 2019 |
| Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ) T Ziemssen, G Phillips, R Shah, A Mathias, C Foley, C Coon, R Sen, ... Journal of neurology 263, 1969-1983, 2016 | 23 | 2016 |
| Quality-adjusted survival of nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone among treatment-naive patients with advanced melanoma: a quality-adjusted time … DF McDermott, R Shah, K Gupte-Singh, J Sabater, L Luo, M Botteman, ... Quality of Life Research 28, 109-119, 2019 | 22 | 2019 |
| An evaluation of the psychometric properties of the sf-12v2 health survey among adults with hemophilia RM Shah, BF Banahan, ER Holmes, AS Patel, M Barnard, R Khanna, ... Health and quality of life outcomes 16, 1-11, 2018 | 21 | 2018 |
| Financial toxicity and its impact on health outcomes and caregiver burden among adult cancer survivors in the USA S Inguva, M Priyadarshini, R Shah, K Bhattacharya Future Oncology 18 (13), 1569-1581, 2022 | 19 | 2022 |
| Economic and humanistic burden associated with depression and anxiety among adults with non-communicable chronic diseases (NCCDs) in the United States E Armbrecht, R Shah, GW Poorman, L Luo, JM Stephens, B Li, ... Journal of multidisciplinary healthcare, 887-896, 2021 | 18 | 2021 |
| A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of nivolumab versus everolimus in advanced renal cell carcinoma (aRCC) R Shah, M Botteman, CT Solem, L Luo, J Doan, D Cella, RJ Motzer Clinical genitourinary cancer 17 (5), 356-365. e1, 2019 | 14 | 2019 |
| Cardiovascular hazards of insufficient treatment of depression among patients with known cardiovascular disease: a propensity score adjusted analysis S Bangalore, R Shah, E Pappadopulos, CG Deshpande, A Shelbaya, ... European Heart Journal-Quality of Care and Clinical Outcomes 4 (4), 258-266, 2018 | 14 | 2018 |
| Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia PJ Goebell, R Raina, S Chen, S Rege, R Shah, JP Grossman, ... Future Oncology 20 (14), 903-918, 2024 | 13 | 2024 |
| Treatment characteristics for nonmetastatic castration-resistant prostate cancer in the United States, Europe and Japan R Shah, M Botteman, R Waldeck Future Oncology 15 (35), 4069-4081, 2019 | 12 | 2019 |
| Comparative effectiveness of coronary artery bypass grafting (CABG) surgery and percutaneous coronary intervention (PCI) in elderly patients with diabetes R Shah, Y Yang, JP Bentley, BF Banahan III Current Medical Research and Opinion 32 (11), 1891-1898, 2016 | 12 | 2016 |
| Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the … MP Barretina-Ginesta, BJ Monk, S Han, B Pothuri, A Auranen, DM Chase, ... Therapeutic Advances in Medical Oncology 14, 17588359221126149, 2022 | 11 | 2022 |
| Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data V Strand, R Shah, C Atzinger, J Zhou, J Clewell, A Ganguli, N Tundia Current Medical Research and Opinion, 1-8, 2019 | 11 | 2019 |